CoChat
Sign Up
Cited by 10Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Open access
Dubois, Bruno, López‑Arrieta, Jesús, Lipschitz, Stanley, Doskas, Triantafyllos, Spiru, Luiza, Moroz, Svitlana, Venger, Olena, Vermersch, Patrick, Moussy, Alain, Mansfield, Colin D., Hermine, Olivier, Tsolaki, Magda, for the AB09004 Study Group Investigators·2023·Alzheimer's Research & Therapy
DOI 10.1186/s13195-023-01230-9PMC PMC10122276
Open this paper in CoChat — free accountOpen PDF

Overview

Integrity signals

Registry

Crossref · 10.1186/s13195-023-01230-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Metadata

Authors
Dubois, B., López‑Arrieta, J., Lipschitz, S., Doskas, T., Spiru, L., Moroz, S., Venger, O., Vermersch, P., Moussy, A., Mansfield, C. D., Hermine, O., Tsolaki, M., & for the AB09004 Study Group Investigators
Affiliations
  • Sorbonne Université (FR)
  • Carol Davila University of Medicine and Pharmacy (RO)
  • I.Horbachevsky Ternopil National Medical University (UA)
  • Inserm (FR)
  • AB Science (France) (FR)
  • Hôpital Necker-Enfants Malades (FR)
  • Aristotle University of Thessaloniki (GR)
Corresponding author
  • Dubois, Bruno
  • Hermine, Olivier
ORCID
Venue
Alzheimer's Research & Therapy
Publisher
Springer Science and Business Media LLC
Published
2023-04-22
Volume
15
Issue
1
Pages
85-85
ISSN
1758-9193 (ISSN-L)
DOI
10.1186/s13195-023-01230-9
PMC
PMC10122276
OpenAlex
W4366769918
Cited by
10
References
1
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 1
Type
journal article
Language
en
Open access
Licence
Locations
  • Alzheimer s Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
masitinib, Alzheimer's disease, mild to moderate Alzheimer's disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review